Beroni Group Limited announced that it has received notification from its European Authorized Representative, CMC Medical Devices & Drugs SL, that its latest enhanced COVID-19 Antigen Rapid Test Kit - Colloidal Gold Method (Rapid Test Kit) has complied with the applicable essential requirements of the council directive 98/79/EEC in vitro diagnostics as amended. Since its launch in 2020, the Rapid Test Kit has been further optimized and upgraded with greatly improved performance indicators. The enhanced Rapid Test Kit is not only simple and convenient to use but also is further improved with faster detection time and higher level of accuracy.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 AUD | -20.80% | -.--% | -.--% |
03-15 | Beroni Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Beroni Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 60.68M | |
+31.37% | 588B | |
-2.78% | 364B | |
+20.54% | 326B | |
+5.57% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.04% | 167B | |
+0.27% | 161B |
- Stock Market
- Equities
- BTG Stock
- News Beroni Group Limited
- Beroni Group Limited Announces That It Has Received Notification from Its European Authorized Representative